X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON LTD vs PIRAMAL ENTERPRISES - Comparison Results

BIOCON LTD    Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON LTD PIRAMAL ENTERPRISES BIOCON LTD/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 41.4 8.2 503.3% View Chart
P/BV x 7.2 1.5 478.6% View Chart
Dividend Yield % 0.2 1.1 14.8%  

Financials

 BIOCON LTD   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    BIOCON LTD
Mar-18
PIRAMAL ENTERPRISES
Mar-18
BIOCON LTD/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs1,1883,083 38.5%   
Low Rs3051,902 16.0%   
Sales per share (Unadj.) Rs68.7589.7 11.7%  
Earnings per share (Unadj.) Rs7.6284.0 2.7%  
Cash flow per share (Unadj.) Rs14.0310.5 4.5%  
Dividends per share (Unadj.) Rs1.0025.00 4.0%  
Dividend yield (eoy) %0.11.0 13.4%  
Book value per share (Unadj.) Rs86.31,467.0 5.9%  
Shares outstanding (eoy) m600.00180.27 332.8%   
Bonus/Rights/Conversions ISIS-  
Price / Sales ratio x10.94.2 257.0%   
Avg P/E ratio x98.98.8 1,126.5%  
P/CF ratio (eoy) x53.48.0 665.7%  
Price / Book Value ratio x8.61.7 508.8%  
Dividend payout %13.28.8 150.4%   
Avg Mkt Cap Rs m447,900449,332 99.7%   
No. of employees `0006.16.8 89.9%   
Total wages/salary Rs m9,31119,881 46.8%   
Avg. sales/employee Rs Th6,705.815,535.6 43.2%   
Avg. wages/employee Rs Th1,514.22,905.4 52.1%   
Avg. net profit/employee Rs Th736.97,482.5 9.8%   
INCOME DATA
Net Sales Rs m41,234106,310 38.8%  
Other income Rs m2,0622,595 79.5%   
Total revenues Rs m43,296108,906 39.8%   
Gross profit Rs m8,29151,599 16.1%  
Depreciation Rs m3,8514,773 80.7%   
Interest Rs m61529,783 2.1%   
Profit before tax Rs m5,88719,638 30.0%   
Minority Interest Rs m2132,801 7.6%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569-28,764 -5.5%   
Profit after tax Rs m4,53151,203 8.8%  
Gross profit margin %20.148.5 41.4%  
Effective tax rate %26.7-146.5 -18.2%   
Net profit margin %11.048.2 22.8%  
BALANCE SHEET DATA
Current assets Rs m41,486118,154 35.1%   
Current liabilities Rs m21,413462,260 4.6%   
Net working cap to sales %48.7-323.7 -15.0%  
Current ratio x1.90.3 758.0%  
Inventory Days Days6427 240.7%  
Debtors Days Days9447 202.4%  
Net fixed assets Rs m50,661113,727 44.5%   
Share capital Rs m3,000361 832.2%   
"Free" reserves Rs m48,808264,093 18.5%   
Net worth Rs m51,808264,454 19.6%   
Long term debt Rs m17,898242,206 7.4%   
Total assets Rs m99,897726,834 13.7%  
Interest coverage x10.61.7 637.1%   
Debt to equity ratio x0.30.9 37.7%  
Sales to assets ratio x0.40.1 282.2%   
Return on assets %5.211.1 46.2%  
Return on equity %8.719.4 45.2%  
Return on capital %9.610.3 93.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05815,110 79.8%   
Fx outflow Rs m7,3484,298 171.0%   
Net fx Rs m4,71010,813 43.6%   
CASH FLOW
From Operations Rs m6,621-159,666 -4.1%  
From Investments Rs m-6,840-17,677 38.7%  
From Financial Activity Rs m-2,397186,503 -1.3%  
Net Cashflow Rs m-2,6129,364 -27.9%  

Share Holding

Indian Promoters % 40.4 52.9 76.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 4.0 210.0%  
FIIs % 10.7 26.6 40.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 16.5 120.6%  
Shareholders   109,995 93,274 117.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON LTD With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  ABBOTT INDIA  

Compare BIOCON LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Recapitalisation Package for PSBs: The Pros & Cons(Podcast)

Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY19); Net Profit Down 152.5% (Quarterly Result Update)

Aug 1, 2018 | Updated on Aug 1, 2018

For the quarter ended June 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 1 bn (down 152.5% YoY). Sales on the other hand came in at Rs 29 bn (up 28.8% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

The 4-Point Plan to Accelerate India to a 10 Trillion Dollar Economy(The 5 Minute Wrapup)

Feb 12, 2019

Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.

The Train to 'Small-Cap-Profits Land' is Back on the Station!(Profit Hunter)

Feb 15, 2019

Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON LTD SHARE PRICE


Feb 22, 2019 (Close)

TRACK BIOCON LTD

  • Track your investment in BIOCON LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

BIOCON LTD - DISHMAN PHARMA COMPARISON

COMPARE BIOCON LTD WITH

MARKET STATS